---
title: "理解市场 | 恒大物业尾盘跌超 5% 清盘人尚未就潜在交易与任何潜在投标人进行磋商"
description: "恒大物业尾盘跌超 5%，截至发稿，跌 5.36%，报 1.06 港元，成交额 4552.08 万港元。消息面上，恒大物业公布，公司获清盘人告知，至今潜在交易仍处于初步阶段，清盘人仍在考虑收到的非约束性意向要约；目前尚未就有关程序的下一阶段作出任何决定，提交最终建议的时间仍在确定中；及清盘人尚未就潜在交易与任何潜在投标人进行磋商。公开资料显示，9 月 10 日，公司收到控股股东中国恒大及 CEG H"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/261569976.md"
published_at: "2025-10-17T07:44:03.000Z"
---

# 理解市场 | 恒大物业尾盘跌超 5% 清盘人尚未就潜在交易与任何潜在投标人进行磋商

> 恒大物业尾盘跌超 5%，截至发稿，跌 5.36%，报 1.06 港元，成交额 4552.08 万港元。消息面上，恒大物业公布，公司获清盘人告知，至今潜在交易仍处于初步阶段，清盘人仍在考虑收到的非约束性意向要约；目前尚未就有关程序的下一阶段作出任何决定，提交最终建议的时间仍在确定中；及清盘人尚未就潜在交易与任何潜在投标人进行磋商。公开资料显示，9 月 10 日，公司收到控股股东中国恒大及 CEG Holdings 清盘人接洽函，指已就潜在出售公司股份与相关有意方订立保密协议，且已从其中部分的有意方收到不具约束力的指示性要约。

智通财经 APP 获悉，恒大物业 (06666) 尾盘跌超 5%，截至发稿，跌 5.36%，报 1.06 港元，成交额 4552.08 万港元。

消息面上，恒大物业公布，公司获清盘人告知，至今潜在交易仍处于初步阶段，清盘人仍在考虑收到的非约束性意向要约；目前尚未就有关程序的下一阶段作出任何决定，提交最终建议的时间仍在确定中；及清盘人尚未就潜在交易与任何潜在投标人进行磋商。

公开资料显示，9 月 10 日，公司收到控股股东中国恒大及 CEG Holdings 清盘人接洽函，指已就潜在出售公司股份与相关有意方订立保密协议，且已从其中部分的有意方收到不具约束力的指示性要约。

### Related Stocks

- [06666.HK - 恒大物业](https://longbridge.com/zh-CN/quote/06666.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Evergrande Property Services - liquidators do not intend to consider any new non-binding indicative offers | Evergrande Property Services - liquidators do not intend to consider any new non-binding indicative offers | [Link](https://longbridge.com/zh-CN/news/270251407.md) |
| Evergrande Property Services says liquidators still considering non-binding indicative offers received thus far | Evergrande Property Services says liquidators still considering non-binding indicative offers received thus far | [Link](https://longbridge.com/zh-CN/news/261292082.md) |
| Sino Biopharmaceutical Gains NMPA Approval for Benmelstobart in Stage III NSCLC Maintenance Therapy | Sino Biopharmaceutical Limited has received approval from China's National Medical Products Administration (NMPA) for a  | [Link](https://longbridge.com/zh-CN/news/276015218.md) |
| Sino Biopharm Wins China Nod for New Lung Cancer Use of PD-L1 Drug | Sino Biopharmaceutical has received Chinese regulatory approval for its PD-L1 inhibitor, benmelstobart, for use as maint | [Link](https://longbridge.com/zh-CN/news/276016059.md) |
| Evergrande Property Services Invites Updated Bids as Takeover Talks Continue | Evergrande Property Services Group Ltd. has invited selected bidders to conduct further due diligence and submit updated | [Link](https://longbridge.com/zh-CN/news/272407592.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。